143 related articles for article (PubMed ID: 36668866)
1. Discovery of the Nicotinic Receptor Toxin Anabaseine in a
Kem WR; Rocca JR; Johnson JV; Junoy J
Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668866
[TBL] [Abstract][Full Text] [Related]
2. New Pyridyl and Dihydroisoquinoline Alkaloids Isolated from the Chevron Nemertean
Kem WR; Soti F; Rocca JR; Johnson JV
Mar Drugs; 2024 Mar; 22(4):. PubMed ID: 38667758
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist.
Kem WR
Invert Neurosci; 1997; 3(2-3):251-9. PubMed ID: 9783447
[TBL] [Abstract][Full Text] [Related]
4. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.
Kem WR; Mahnir VM; Papke RL; Lingle CJ
J Pharmacol Exp Ther; 1997 Dec; 283(3):979-92. PubMed ID: 9399967
[TBL] [Abstract][Full Text] [Related]
5. A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.
Xing H; Keshwah S; Rouchaud A; Kem WR
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32053997
[TBL] [Abstract][Full Text] [Related]
6. Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine.
Lee ST; Wildeboer K; Panter KE; Kem WR; Gardner DR; Molyneux RJ; Chang CW; Soti F; Pfister JA
Neurotoxicol Teratol; 2006; 28(2):220-8. PubMed ID: 16488116
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the Possible Pharmacologically Active Forms of the Nicotinic Acetylcholine Receptor Agonist Anabaseine.
Andrud K; Xing H; Gabrielsen B; Bloom L; Mahnir V; Lee S; Green BT; Lindstrom J; Kem W
Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31671780
[TBL] [Abstract][Full Text] [Related]
8. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
Kem WR
Behav Brain Res; 2000 Aug; 113(1-2):169-81. PubMed ID: 10942043
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of barnacle larval settlement and crustacean toxicity of some hoplonemertine pyridyl alkaloids.
Kem WR; Soti F; Rittschof D
Biomol Eng; 2003 Jul; 20(4-6):355-61. PubMed ID: 12919820
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.
de Fiebre CM; Meyer EM; Henry JC; Muraskin SI; Kem WR; Papke RL
Mol Pharmacol; 1995 Jan; 47(1):164-71. PubMed ID: 7838125
[TBL] [Abstract][Full Text] [Related]
11. Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.
Arias HR; Xing H; Macdougall K; Blanton MP; Soti F; Kem WR
Br J Pharmacol; 2009 May; 157(2):320-30. PubMed ID: 19338581
[TBL] [Abstract][Full Text] [Related]
12. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
[TBL] [Abstract][Full Text] [Related]
13. Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine(3A) receptor.
Machu TK; Hamilton ME; Frye TF; Shanklin CL; Harris MC; Sun H; Tenner TE; Soti FS; Kem WR
J Pharmacol Exp Ther; 2001 Dec; 299(3):1112-9. PubMed ID: 11714901
[TBL] [Abstract][Full Text] [Related]
14. Activation and Desensitization of Peripheral Muscle and Neuronal Nicotinic Acetylcholine Receptors by Selected, Naturally-Occurring Pyridine Alkaloids.
Green BT; Lee ST; Welch KD; Cook D; Kem WR
Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27384586
[TBL] [Abstract][Full Text] [Related]
15. Effects at a distance in alpha 7 nAChR selective agonists: benzylidene substitutions that regulate potency and efficacy.
Papke RL; Meyer EM; Lavieri S; Bollampally SR; Papke TA; Horenstein NA; Itoh Y; Porter Papke JK
Neuropharmacology; 2004 Jun; 46(7):1023-38. PubMed ID: 15081799
[TBL] [Abstract][Full Text] [Related]
16. The Toxins of Nemertean Worms.
Göransson U; Jacobsson E; Strand M; Andersson HS
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30781381
[TBL] [Abstract][Full Text] [Related]
17. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.
Stevens KE; Kem WR; Mahnir VM; Freedman R
Psychopharmacology (Berl); 1998 Apr; 136(4):320-7. PubMed ID: 9600576
[TBL] [Abstract][Full Text] [Related]
18. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.
Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS
Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex.
Summers KL; Kem WR; Giacobini E
Jpn J Pharmacol; 1997 Jun; 74(2):139-46. PubMed ID: 9243321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
